Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation

Decreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth res...

Full description

Bibliographic Details
Main Authors: Natalia I Gokina, Siu-Lung eChan, Abbie C Chapman, Karen eOppenheimer, Thomas eJetton, Marilyn J Cipolla
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/full
_version_ 1818318306639085568
author Natalia I Gokina
Siu-Lung eChan
Abbie C Chapman
Karen eOppenheimer
Thomas eJetton
Marilyn J Cipolla
author_facet Natalia I Gokina
Siu-Lung eChan
Abbie C Chapman
Karen eOppenheimer
Thomas eJetton
Marilyn J Cipolla
author_sort Natalia I Gokina
collection DOAJ
description Decreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth restriction during pregnancy is not known. Here, pregnant Sprague-Dawley rats (n=11/group) were treated during the second half of pregnancy with the PPARγ inhibitor GW9662 (10 mg/kg/day in food) or vehicle. Pregnancy outcome and PPARγ mRNA, vasodilation and structural remodeling were determined in maternal uterine and mesenteric arteries. PPARγ was expressed in uterine vascular tissue of both non-pregnant and pregnant rats with ~2-fold greater expression in radial vs. main uterine arteries. PPARγ mRNA levels were significantly higher in uterine compared to mesenteric arteries. GW9662 treatment during pregnancy did not affect maternal physiology (body weight, glucose, blood pressure), mesenteric artery vasodilation or structural remodeling of uterine and mesenteric vessels. Inhibition of PPARγ for the last 10 days of gestation caused decreased fetal weights on both day 20 and 21 of gestation that was associated with impaired vasodilation of radial uterine arteries in response to acetylcholine and sodium nitroprusside. These results define an essential role of PPARγ in the control of uteroplacental vasodilatory function during pregnancy, an important determinant of blood flow to the placenta and fetus. Strategies that target PPARγ activation in the uterine circulation could have important therapeutic potential in treatment of pregnancies complicated by hypertension, diabetes or preeclampsia.
first_indexed 2024-12-13T09:51:08Z
format Article
id doaj.art-ce6f09d4621045d6a4a1d50c5afd3af2
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-13T09:51:08Z
publishDate 2013-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-ce6f09d4621045d6a4a1d50c5afd3af22022-12-21T23:51:56ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2013-07-01410.3389/fphys.2013.0018452446Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine VasodilationNatalia I Gokina0Siu-Lung eChan1Abbie C Chapman2Karen eOppenheimer3Thomas eJetton4Marilyn J Cipolla5University of VermontUniversity of VermontUniversity of VermontUniversity of VermontUniversity of VermontUniversity of VermontDecreased peroxisome proliferator-activated receptor gamma (PPARγ) activity is thought to have a major role in preeclampsia through abnormal placental development. However, the role of PPARγ in adaptation of the uteroplacental vasculature that may lead to placental hypoperfusion and fetal growth restriction during pregnancy is not known. Here, pregnant Sprague-Dawley rats (n=11/group) were treated during the second half of pregnancy with the PPARγ inhibitor GW9662 (10 mg/kg/day in food) or vehicle. Pregnancy outcome and PPARγ mRNA, vasodilation and structural remodeling were determined in maternal uterine and mesenteric arteries. PPARγ was expressed in uterine vascular tissue of both non-pregnant and pregnant rats with ~2-fold greater expression in radial vs. main uterine arteries. PPARγ mRNA levels were significantly higher in uterine compared to mesenteric arteries. GW9662 treatment during pregnancy did not affect maternal physiology (body weight, glucose, blood pressure), mesenteric artery vasodilation or structural remodeling of uterine and mesenteric vessels. Inhibition of PPARγ for the last 10 days of gestation caused decreased fetal weights on both day 20 and 21 of gestation that was associated with impaired vasodilation of radial uterine arteries in response to acetylcholine and sodium nitroprusside. These results define an essential role of PPARγ in the control of uteroplacental vasodilatory function during pregnancy, an important determinant of blood flow to the placenta and fetus. Strategies that target PPARγ activation in the uterine circulation could have important therapeutic potential in treatment of pregnancies complicated by hypertension, diabetes or preeclampsia.http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/fullPregnancyVasodilationPPARγPreeclampsiauterine and mesenteric artery
spellingShingle Natalia I Gokina
Siu-Lung eChan
Abbie C Chapman
Karen eOppenheimer
Thomas eJetton
Marilyn J Cipolla
Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
Frontiers in Physiology
Pregnancy
Vasodilation
PPARγ
Preeclampsia
uterine and mesenteric artery
title Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
title_full Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
title_fullStr Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
title_full_unstemmed Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
title_short Inhibition of PPARγ during Rat Pregnancy Causes Intrauterine Growth Restriction and Attenuation of Uterine Vasodilation
title_sort inhibition of pparγ during rat pregnancy causes intrauterine growth restriction and attenuation of uterine vasodilation
topic Pregnancy
Vasodilation
PPARγ
Preeclampsia
uterine and mesenteric artery
url http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00184/full
work_keys_str_mv AT nataliaigokina inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation
AT siulungechan inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation
AT abbiecchapman inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation
AT kareneoppenheimer inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation
AT thomasejetton inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation
AT marilynjcipolla inhibitionofppargduringratpregnancycausesintrauterinegrowthrestrictionandattenuationofuterinevasodilation